Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Víctor Pérez-Sánchez"'
Autor:
Antonio Maffuz-Aziz, Efraín Salas González, Guadalupe Cervantes-Sánchez, Jesús Cárdenas-Sánchez, Vicente Valero Castillo, Verónica Bautista Piña, Víctor Pérez-Sánchez, Aura Argentina Erazo-Valle-Solís, Juan Enrique Bargallo-Rocha, Laura Torrecillas-Torres, Christian H. Flores-Balcázar, Adela Poitevin-Chacón
Publikováno v:
Gaceta Mexicana de Oncolog�a. 16
Autor:
Verónica Bautista-Piña, Christian H. Flores-Balcázar, Claudia Arce-Salinas, Aura Erazo Valle-Solís, Vicente Valero-Castillo, Adela Poitevin-Chacón, Efraín Salas-González, Laura Torrecillas-Torres, Juan Enrique Bargallo-Rocha, Jesús Cárdenas-Sánchez, Ana Lluch-Hernández, Antonio Maffuz-Aziz, Guadalupe Cervantes-Sánchez, Víctor Pérez-Sánchez
Publikováno v:
Gaceta Mexicana de Oncolog�a. 18
Autor:
Héctor Martínez-Gregorio, Felipe Vaca-Paniagua, Rosalía Quezada-Urban, Paula Cabrera-Galeana, Cecilia Frecha, Javier César Mejía-Gómez, Ernesto Rojas-Jiménez, Fernando Vallejo-Lecuona, Héctor Aquiles Maldonado-Martínez, Víctor Pérez-Sánchez, Enrique Bargallo-Rocha, Clara Díaz-Velásquez, Fany Iris Porras-Reyes, Sandra Perdomo, Luis I. Terrazas, Maybelline Robles-Estrada, Luis A. Herrera, Maritza Ramos-Ramírez, Aldo de la Cruz-Montoya, Javier Oliver, Yolanda I. Chirino
Publikováno v:
Cancers
Volume 13
Issue 20
Cancers, Vol 13, Iss 5091, p 5091 (2021)
Volume 13
Issue 20
Cancers, Vol 13, Iss 5091, p 5091 (2021)
Simple Summary Triple-negative breast cancer (TNBC) is a clinically, phenotypically, and molecularly heterogeneous disease. This heterogeneity is a factor that negatively impacts therapy response. To analyze evolutionary patterns and the genomic alte
Autor:
Enrique Bargallo-Rocha, Luis I. Terrazas, Clara Díaz-Velásquez, Fernando Vallejo-Lecuona, Fany Iris Porras Reyes, Aldo de la Cruz-Montoya, Javier Oliver, Javier César Mejía-Gómez, Sandra Perdomo, Víctor Pérez-Sánchez, Héctor Martínez Gregorio, Paula Cabrera-Galeana, Cecilia Frecha, Maritza Ramos-Ramírez, Yolanda I. Chirino, Rosalía Quezada-Urban, Felipe Vaca-Paniagua, Luis A. Herrera, Ernesto Rojas-Jiménez, Maybelline Robles-Estrada, Héctor Maldonado-Martinez
Publikováno v:
Genes, Vol 11, Iss 1367, p 1367 (2020)
Genes
Volume 11
Issue 11
Repositorio U. El Bosque
Universidad El Bosque
instacron:Universidad El Bosque
Genes
Volume 11
Issue 11
Repositorio U. El Bosque
Universidad El Bosque
instacron:Universidad El Bosque
Triple-negative breast cancer (TNBC) presents a marked diversity at the molecular level, which promotes a clinical heterogeneity that further complicates treatment. We performed a detailed whole exome sequencing profile of 29 Mexican patients with lo
Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
Autor:
Víctor Pérez-Sánchez, Fernando Lara-Medina, R. Marisol Quintero, Alejandro Mohar, Alberto Alvarado-Miranda, Wendy Muñoz-Montaño, Fany Iris Porras-Reyes, Oscar Arrieta, Cynthia Villarreal-Garza, Enrique Bargallo-Rocha, Ignacio Del Carmen, Paula Cabrera-Galeana
Publikováno v:
The Oncologist. 23:670-678
Background Several breast cancer (BC) trials have adopted pathological complete response (pCR) as a surrogate marker of long-term treatment efficacy. In patients with luminal subtype, pCR seems less important for outcome prediction. BC is a heterogen
Autor:
Robin Shaw-Dulin, Fany Iris Porras-Reyes, Laura Marysol Álvarez-Guadarrama, M. Patricia Pérez-Badillo, Víctor Pérez-Sánchez, Cecilia Magdalena Pavón-Hernández, Alejandro Javier España-Ferrufino, Isabel Sollozo-Dupont, Yolanda Villaseñor-Navarro, Héctor Alejandro Domínguez-Hernández
Publikováno v:
Case Reports in Radiology, Vol 2017 (2017)
Case Reports in Radiology
Case Reports in Radiology
The incidence of reported pseudoangiomatous stromal hyperplasia (PASH), as well as the variability and severity of clinical presentations, is increasing in the literature. In parallel, several authors posit the need for an improved classification of
Autor:
María Tereza Nieto-Coronel, Claudia Arce-Salinas, Raúl Díaz-Molina, Jessica Elizabeth Salazar-Campos, Víctor Pérez-Sánchez
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 62, Iss 1, Pp 125-128 (2019)
Lymphoepithelioma is a rare clinical entity, first was described in nasopharynx, and have been reported in another organs. Lymphoepithelioma-like carcinoma (LEC) of the breast is an undifferentiated carcinoma. Approximately 32 cases have been describ
Autor:
Víctor Pérez-Sánchez, Alejandro Mohar-Betancourt, Juliette Plun-Favreau, Juan Enrique Bargallo-Rocha, Rafael Vázquez-Romo, William J. Valentine, Héctor Martínez-Said, Cynthia Villarreal-Garza, Fernando Lara-Medina, Barnaby Hunt, Robin Shaw-Dulin
Publikováno v:
Advances in Therapy. 32:239-253
The 21-gene breast cancer assay (Oncotype DX®; Genomic Health, Inc.) is a validated diagnostic test that predicts the likelihood of adjuvant chemotherapy benefit and 10-year risk of distant recurrence in patients with hormone-receptor-positive, huma
Autor:
Fany Iris Porras-Reyes, Héctor Aquiles Maldonado-Martínez, Víctor Pérez-Sánchez, Isabel Sollozo-Dupont, Fernando Lara-Medina, Yolanda Villaseñor-Navarro, Francisco O. García-Pérez, Quetzali Pitalua-Cortes, Wendy Pérez-Báez, Juan Matus-Santos, Irma Soldevilla-Gallardo
Publikováno v:
BJR Case Reports
Molecular identification of a metastatic tumour without the inconvenience of a biopsy and the time required for pathological characterization is possible using molecular imaging. Here, we present the case of a patient with breast cancer in whom 68Ga-
Autor:
Eduardo A. García-Zepeda, Alejandro Mohar-Betancourt, Vania Gómez-Romero, Isis Trujillo-Gonzalez, Angeles C. Tecalco-Cruz, Víctor Pérez-Sánchez, Rafael Cervantes-Roldán, Tonatiuh Barrios-García, Félix Recillas-Targa, Sandra Reyes-Carmona, Iván Meneses-Morales, Alfonso León-Del-Río, Erika Mendez-Enriquez
Publikováno v:
Nucleic Acids Research
The estrogen receptor alpha (ERα) is a ligand-activated transcription factor that possesses two activating domains designated AF-1 and AF-2 that mediate its transcriptional activity. The role of AF-2 is to recruit coregulator protein complexes capab